Good day everyone, welcome to the MediaAlpha fourth quarter and full year 2022 earnings call. Today's call is being recorded. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star one on your telephone keypad. If you would like to remove yourself from the queue, that is star one again. I would now like to turn the conference over to Denise Garcia, Investor Relations. Please go ahead. Thank you, Lisa. After the market closed today, MediaAlpha issued a press release and shareholder letter announcing results for the fourth quarter and full year ended December 31, 2022. These documents are available in the investors section of our website and w e will be referring to them on this call. Our discussion today will include forward-looking statements about our business and our outlook for future financial results including our financial guidance for the first quarter of 2023 which are based on assumptions, forecasts, expectations and information currently available to management. These forward-looking statements are subject to risks and uncertainties that could cause future results or events to differ materially from those reflected in those statements. Please refer to the company's SEC filings including its annual report on Form 10-K and its quarterly reports on Form 10-Q for a fuller explanation of those risks and uncertainties and the limits applicable to forward-looking statements. These forward-looking statements are based on assumptions as of today, February 23, 2023 and the company undertakes no obligation to revise or update them. In addition, on today's call, we will be referring to certain actual and projected financial metrics of MediaAlpha that are presented on a non-GAAP basis. This includes adjusted EBITDA, which we present in order to supplement your understanding and assessment of our financial performance. Non-GAAP measures should not be considered as a substitute for or superior to financial measures calculated in accordance with GAAP. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our press release and the shareholder letter issued today. Finally, I'd like to remind everyone that this call is being recorded and will be made available for replay via a link on the investors section of the company's website @ investors.mediaalpha.com. Now I'll turn the call over to Steve and Pat for a few introductory remarks before opening the call to your questions. Hey, thanks, Denise. Hi, everyone, welcome to our fourth quarter and full year 2022 earnings call. I'd like to make a few observations before turning the call over to Pat for his comments. We saw strong performance in our health insurance vertical in the fourth quarter. This was driven by a sharp year-over-year increase in demand from Medicare Advantage carriers and we remain bullish about the long-term growth opportunity with this segment. The market for Medicare Advantage is expected to continue to outpace growth of Medicare as a whole and seniors are increasingly shopping for Medicare Advantage policies online; with carriers prioritizing direct relationships with their members, we expect health insurance companies to continue to increase their direct marketing investments which represent tremendous long-term tailwinds for this business. Turning to our P&C insurance vertical, we believe Q4 was the low point of this auto insurance hard market cycle and we're optimistic that 2023 will be a better year than 2022. Driven by the resumption of marketing investments by one leading carrier who was early to achieve rate adequacy, we expect spend in our P&C marketplace to roughly double from Q4 to Q1, which is well above typical seasonal patterns. As the year progresses, we expect more carriers to return to growth mode as rate increases continue to be approved and as underwriting profitability is gradually restored; c oupled with the heightened consumer shopping behavior that will result from these double-digit pricing increases, we believe that this has the potential to create market conditions to support outsized growth coming out of this hard market. Taking a step back, it's now clear that 2022 will be remembered as one of the most difficult years ever for the P&C insurance industry. Our ability to deliver adjusted EBITDA and free cash flow in this unprecedented market environment not only speaks to the efficiency of our marketplace model but also to our team and culture. As a bootstrap company, doing more with less has always been in our DNA and I couldn't be prouder of how the entire MediaAlpha team rose to the occasion this past year, enabling us to flatten our expense growth to meet these challenging conditions. Looking ahead, we continue to believe MediaAlpha can be a multi-billion dollar company due to the vast size of our addressable market and our highly differentiated marketplace model. We look forward to executing on this market opportunity and delivering strong top and bottom line growth in the upcoming years. With that, I'll turn the call over to Pat before we open the call to your questions. Thanks, Steve. We exceeded our expectations during the fourth quarter due to better top-line growth in our health vertical and favorable expenses excluding non-cash items. We remain highly disciplined in our spending and continue to identify efficiency opportunities across the business. I'll start with our balance sheet and cash flow. During the fourth quarter, we paid down $7.4 million of debt, bringing our cumulative debt repayments over the past three quarters to $27.1 million. We were pleased to generate $28.2 million of full year free cash flow during what we believe was the bottom of the current P&C cycle and w e ended the year with $14.5 million of cash and considerable headroom relative to our debt covenants, leaving us well positioned to invest in growth coming out of the P&C hard market. Moving to our Q1 2023 guidance, we expect P&C transaction value to nearly double compared with Q4 of 2022, d riven by an improvement in market conditions in our P&C vertical in addition to normal seasonality. Although we are encouraged by these early signs of recovery, we still expect P&C transaction value to be well below Q1 2022 levels. In our health insurance vertical, we expect modest year-over-year growth in transaction value as we continue deepening our relationships with key carriers. For the life and other verticals, we expect transaction value to decline year-over-year at a similar rate as in Q4 of 2022. As a result of this, we expect Q1 transaction value for the company to be between $180 million to `$195 million, a year-over-year decrease of 22% at the midpoint. We expect revenue to range from $106 million to $116 million, a year-over-year decrease of 22% at the midpoint. Lastly, we expect adjusted EBITDA to be between $5.5 million to $7.5 million, a year-over-year decrease of 9% at the midpoint. We expect Q1 adjusted EBITDA margin to improve modestly year-over-year at the midpoint as we expect expenses to be roughly flat compared with Q4 of 2022. We expect quarterly expenses for the rest of this year to remain flat to up slightly as compared with Q1. Due to the uncertainty around the timing and slope of the P&C market recovery, we are not providing full year 2023 guidance; We believe the inherent operating leverage in our model and our ongoing expense discipline creates the potential for strong adjusted EBITDA growth moving forward. With that, operator, we are ready for the first question. Thank you. Once again, everyone, that is star one on your telephone to ask a question. We'll take our first question from Michael Graham with Canaccord. Hey, thank you, and thanks for the information, guys. I think it's a big statement that you think Q4 is the low point for P&C. I know you were one of the ones to say that this hard market might last longer than most people expected, I think that's a, that's a good positive statement. I just wanted to ask about the in past cycles, when you see, like one carrier coming on strong here with rate adequacy as you outlined in your shareholder letter, you know, can you just talk about, like, the FOMO involved with, you know, other carriers then, you know, sort of coming to market? You know, do you have any thoughts on, like, historically what a typical time lag has been, you know, between sort of the leaders getting rate adequacy and starting to spend more versus some of the others? Hey, Michael, it's Steve. Let's see. It's a great question, a ppreciate your commentary. Yeah, I think the way this market cycle is unfolding is remarkably similar to past, you know, hard market cycles where there was one leading carrier who was very early to achieve rate adequacy and restore underwriting profitability, really front-running the rest of the market in a big way and leading back into growth mode, n ot just leaning, I would say jumping. Now, you know, what we know is that this will, you know, this will precede, you know, the return of demand from a broader base of carriers. In terms of the overall timing, I think that's when I think the parallels between the last hard market and this hard market, you know, kind of stop because really what you're gonna see is each carrier being on their own timeline, you know, based on the rate adequacy that they've been able to achieve and how long each of the carriers will wait until these rate increases earn through to improve their underwriting results, you know, before they then, you know, jump back into growth mode themselves. You know, the best that we can tell you is that we expect this to happen, you know, through this year with various carriers coming in at different stages of the year. We do expect this to last into 2024. In terms of just the, you know, the overall timing and is it six months or is it three months that a you know, that a leading carrier is gonna front run the rest of the marketplace, I mean, that's really hard to predict and it's really gonna depend on the individual carriers and their ability to really get their rates to a good place and where they need to be in terms of their underwriting performance before they really jump back into growth mode. All right. Great. Thanks a lot, Steve. We'll take our next question from Cory Carpenter with J.P. Morgan. Thanks for the question. Steve, one for you and one for Pat, j ust kind of following up on that one, some of the recent carrier results have been, I think it's fair to say disappointing and used car prices have actually started to rise this year; j ust curious more recently what you're hearing in your conversations with carriers around those dynamics and any risk that it could lead to, you know, further delays for call it some of the laggards and t hen, maybe for Pat, just on the guide, you mentioned seasonality and then also improved carrier spend. Any way to kind of parse out, you know, the, you know, how much each of those is contributing to your 1Q guide? Thank you. Yeah, sure. You know, we're seeing the same results roll in and certainly I think it is carrier-specific in terms of the tenor of the conversations that we're having with each carrier. You know, there are carriers who have posted stronger results and you see them with a clear trajectory to restoring profitability and you can easily see those carriers coming back into the marketplace, you know, in three to six months. You see other carriers who really are indicating that 2023 or the vast majority of 2023 will be focused on getting their pricing right. In terms of the, you know, unexpected developments, I don't know that we're seeing the same thing or we're hearing that from carriers. I think what you've seen is, you know, over the last six quarters, you know, rate increase is really outpacing increase in loss costs which really means that the industry is finally digging out and you're seeing other things, like California is starting to, you know, approve rate increases for the first time in years. I think overall, when you look at the broader industry, you know, there are some negative signals coming from carriers but as a whole, I do see the entire industry really starting to dig out and t his is reflected in the tenor of the conversations that we're having with each of the carriers which is far more constructive and growth-oriented than they were in past years; w e take that as a really positive sign. There will be some carriers that are laggards that will probably come back into the marketplace, you know, in the first half of 2024 but I would characterize the majority of the carriers that we're talking to, as expecting a return to the marketplace, you know, sometime in 2023. Cory, this is Pat, t o answer the second question just on for our guide for Q1 for P&C and the sequential growth as compared to Q4 -- how much of that is seasonality versus recovery, y ou know, I think if you look at our results over the last couple of years for Q4 versus Q1, you would see that, you know, in a typical year for us, for P&C, it would be up, you know, 10% or 15% at the low end, 30% at the high end, you can, you know, think of that as probably being, you know, seasonality, just the consumer shop more in Q1 than Q4 and t he balance of it being, you know, recovery trends, you know, be they volume or price. Great. Thank you both. Thanks, Cory. We'll take our next question from Meyer Shields with KBW. Thanks so much, a couple of, I guess, small numerical questions -- The G&A expense in the quarter was higher than it had been running and I was hoping you could talk through, whether there's anything unusual in that. Yeah. You know, the, you know, would say nothing, you know, overly unusual on that; I think there were, you know, definitely some items that fell into that would be, you know, excluded from adjusted EBITDA in there, so, you know, would say that, you know, is we really think of kind of managing the business to the adjusted EBITDA number and the G&A number, you know, kind of as we, that feeds into adjusted EBITDA has been pretty darn consistent over the last couple of few quarters. No, that's helpful. I guess on a related note, Pat, you mentioned in your prepared remarks, ramping up investments. I was hoping you could talk through sort of the timeline of that -- Is that tightly tied to P&C carrier spend? You know, on that, on that question, Meyer, would say that, you know, we have been managing the business pretty tightly through the hard market; y ou know, I think if you were to look back at where we were on April 1st after we closed the CHT acquisition, you know, we've got fewer people working at the company now and y ou know, I think we're in a spot where we feel like we're adequately resourced now. I think is, you know, we get further into the hard market, could I see us, you know, needing a bit more help on, you know, some of the account teams? You know, yeah, I could -- c ould I see us, you know, investing to unlock some capacity in some other teams? You know, yes, I could. You know, don't think that's imminent in the next, you know, quarter or two and y ou know, as we think about the investment profile of the business, you know, over the next couple of years, you know, our view is that, you know, we are very focused on running efficiently, Steve mentioned in his prepared comments, we're a bootstrap company, and efficiency is in our DNA and we don't plan on losing that focus over time. Okay, perfect, i f I can throw in one more question --` You mentioned, I think, Steve, that the health insurance brokers were pulling back and I think that's very consistent with what we're seeing broadly. Do you have any sense in conversations with them whether that's like a one, two year phenomenon or this is the new reality for them? That's a great question, you know, I'll say that, you know, I think right now it's too early to tell; you know, one encouraging sign that we saw in the last enrollment period was that click spend from the broker segment held up reasonably well. The reason that we see that as an encouraging sign is that that's used to support their own assisted online enrollment channel which we increasingly see as, you know, as a future shopping experience for Medicare Advantage, s o that was a really encouraging sign. I think some of the early results that you're seeing have also been encouraging, you know, from the broker segment. In terms of, you know, where they are in terms of working through their LTV and profitability issues, I think it's a little bit too early to tell whether that's a one-year or a two-year thing. What we do expect over the long term that the demand mix within our marketplace, particularly within our Medicare marketplace, will be a pretty healthy blend of direct carrier spend which we see as a long-term secular trend as we saw within the auto insurance space and a good mix of broker demand as well; t hat's what the distribution channel of this marketplace is gonna look like going forward and we think that that's gonna be reflected in our marketplace as well. Yep. Meyer, this is Pat again. Yeah. I just wanted to follow up on your G&A question; t he big driver of it being down within, or being up was in Q2 and Q3, we had some non-cash write-offs of an earn-out related to an acquisition and you know, they were non-cash items and that's why, you know, it appears as if it was up, but on a, you know, cash basis and cost of operating the business, it was pretty darn consistent. Got it. Perfect. Thank you so much for all the help. Sure. Thanks, Meyer. We'll take our next question from Andrew Kligerman with Credit Suisse. Hey, good evening, f ollow up on the last questions, i n health -- the trend with the brokers, you know, we cover a few companies that have these Med Advantage brokers and they're hurting a lot on these customer acquisition costs; i s that the spot that's really just making it too difficult for them? Is it customer acquisition costs? Is it getting your bid? You know, like when they have to bid on something in your channel, is it just too expensive for them? What's kind of holding them back from being more impactful? Yeah, I think that's a great question. I don't think it's related to customer acquisition costs per se. Okay? Mm-hmm. I think Some of the issues that they've been having is really getting a better grasp of what the expected lifetime value is of the policies that they're acquiring; at the end of the day, when you're in performance marketing and in growth marketing, what you need to do is, you know, understand the expected value of a policy that you sell and then match that to that customer acquisition cost so that you can have a target return on ad spend. If you don't have a granular understanding of really exactly, you know, duration of the policy and what the expected value is that you're gonna extract for that consumer that you're selling a policy to, then you're gonna have a hard time really dialing in the customer acquisition cost so that you're ROI (return on investment) positive with your ad spend. I think it's really the fact that these brokers are getting a better handle on expected LTV, how these differ based on different marketing channels that they have, and then leveraging the granular controls and the programmatic controls that you would have in a marketplace like ours to really be able to match, you know, what you're willing to pay to acquire that consumer with what you expect that consumer, t he value that you can expect to gain from that consumer. It's really that matching is what they need to get right. I think as they get a better understanding of really what the expected retention rates are of their consumers and how these differ based on different marketing channels, we fully expect them to be able to come back into the market and leverage a programmatic channel like ours to match what they're willing to pay with that expected value and it is related to customer acquisition costs in some ways, but it's really about the ability to match that to the expected LTV and I think that's really the nut that they're trying to crack. Okay. Yeah, that is a tough nut to crack and thanks for that thorough explanation, Steve and t hen maybe just digging a little deeper on the P&C Transaction Value, you know, as you were talking about the players, most of them coming back in 2023, how about on a state-by-state basis? Do you see some companies that, you know, may be disinclined to be in certain states, say those on the coast, versus, you know, some other states? I mean, are you seeing some pickup that's mixed among carriers? Maybe you could talk a little bit about that. Hey, I think that's a great question, I think in a normal market environment, that's what you would see, that there are some states in which profitability is challenged -- t hey'll pull back in marketing in those states and really go heavy in states where they actually have established profitability and have a high confidence in their rates; you know, what you'd expect to see coming out of a market like this, is that carriers will start to lean back in those states where they have a high degree of confidence in the rates that they've achieved. I think one of the things that we're seeing in this marketplace that may be a little different than what we saw in the last hard market cycle is that we're seeing less of that kind of behavior; the indications that we're getting from carriers is that their profitability's been challenged severely for the last couple of years. When they come back, they expect to come back in full and they'll come back as the rates start to earn through and actually impact their underwriting profitability and they're not gonna front run rate adequacy, you know, well, full rate adequacy by cherry-picking certain states where they already have rate increases to start to gradually get back into the marketplace. I think what we're gonna expect to see, as the year progresses, is that carriers will really need to establish broader profitability in order to then come back into the marketplace as a whole, as opposed to starting to ease back into the market in those states, where they feel good about their rates. Does that make sense? Yeah, it makes a lot of sense, Steve. Thanks so much. Sure. Our next question comes from Daniel Grosslight with Citi. Hi, guys. Thanks for taking the question. Congrats on the quarter. Let's stick with the health segment here -- you know, there's been some chatter out there in the Medicare Advantage market about a potential slowdown given a less generous advance notice for plan year 2024, o bviously, a lot of is up in the air; I'm curious if you're hearing anything from your partners on that and if there are any levers you can pull if you see a macro slowdown in Medicare Advantage Yeah, I think that's a great question, I mean, I think -- the short answer is it's too early to tell, y ou know, these proposed rates I think came out, you know, fairly recently, like, I think a couple of weeks ago and they won't be finalized until April and y ou know, as you know that there's, you know, there's a healthy debate with the large Health Insurance companies and CMS on really the adequacy of the rate increases that they can expect for 2024. You know, we've been in dialogue with our partners about that and I think, you know, universally, I think the sentiment is that it's really too early to tell. Yeah, okay and you mentioned that health growth is accretive to contribution margin, in your shareholder letter; I was wondering if you could quantify how much better health contribution is than the rest of the business and what are some of the drivers of that accretion? You know, I think in our financials -- I think you can, you know, kind of tease out some of those numbers; t he big difference I would say is that, you know, on the health side, we have a much higher open marketplace mix and we have effectively a higher take rate on the open marketplace side; revenue equals transaction value and we have, you know -- the contribution as a percentage of transaction value is, you know, almost 3x the rate of the private marketplace; y ou know, the mix is more favorable within the health side and so the take rate is quite a bit higher; t hat's one of the reasons why Q4 is our biggest quarter because it's our biggest revenue quarter and it mixes to health. Yeah. Makes sense, then just a housekeeping question -- t here was a big increase in accounts receivable this quarter and it's related. I'm curious if you can talk about what drove that; y ou're, you know, a little bit low on cash now, o bviously, you're very efficient with that. Do you anticipate you'll have to draw on your revolver and kind of what your working capital needs are in 2023? On the AR side, you know, I think that Q4 is a big quarter for us on the health side, w e, you know, have a number of folks that, you know, spent big in the final days of AEP and OEP. Those were, you know, billed, you know, billed at the end of the month; w e had, you know, some AR from that w e've had, you know, since no collection difficulties. You know, from a revolver standpoint, to, you know, just kind of walk through the chronology of it, we drew $25 million on it on April 1st, to fund an acquisition, w e've paid off $20 million of that over the course of 2022, w e still have $5 million outstanding on it and we do not anticipate needing to draw on that going forward. Got it. Thank you. Thanks, Dan. We'll take our next question from Mike Zaremski with BMO. Hey, great. Good evening, moving back to the property and casualty side of the business, curious, you know -- are you seeing your revenues more concentrated than in the past with a, you know, a smaller subset? Do you expect that to continue in the near term? If so, just curious, does that mean, you know, that transaction values per lead, you know, will remain a bit depressed 'cause we, you know, you would need more just participants, meaningful participants in the marketplace to come back in to kind of lift transaction value levels as well? Yeah. Mike, this is Pat, I can take that one; you know, on the concentration on the P&C side -- it has become more concentrated in Q1 versus Q4 and y ou know, that is, you know, caused by one carrier pivoting to growth mode and spending, you know, more on that; you know, the number one spender in Q4 was a lower percentage than they were than they will be in Q1. You know, will that trend continue? You know, I would say it will continue for a while until other carriers start to come back in a big way and then, you know, would expect to see the concentration start to decline. You know, the real question is one of timing, which is, you know, when do you know other carriers start to come back in a big way? You know, when that happens, we have a high degree of confidence that the concentration will start to be a bit more dispersed. On the second part of your question regarding, you know, transaction value per lead, you know, the thing, you know, I can say is that it is up meaningfully in Q1, you know, versus Q4 and y ou know, I think the, you know, the big reason for that is two big reasons, y ou know, one is, you know -- one advertiser is, you know, generally more active and is bidding more; y ou know, secondly -- it's coverage, which is, you know, some states, you know, may have been off or with very low bids and they've, you know, taken those up pretty considerably or turned them back on which is had a positive impact to the overall marketplace. I think the carriers in our marketplace, I think, you know, recognize because of the marketplace model and because of the supply partnerships that we have, that as pricing goes up, they'll get more volume, you know, even if they're the highest given bidder for a given consumer segment and o ur past experience has been that, yes, absolutely, a competitive market environment, you know, will drive up pricing and w e expect to see those competitive dynamics revert back to, you know, a more normalized, you know, situation, you know, as the year progresses. It's been also that our experience that, you know, you only need a small number of major carriers to be back in place to really replicate the competitive dynamics you need to start to get every advertiser really paying based on their expected return on ad spend, independent of competitive considerations. Got it. That's, that's helpful, second question, sticking with P&C -- just curious if any changes in the marketplace in terms of home insurance and bundling or, you know, that's still, you know, obviously a long-term growth driver -- just curious if anything's changing on that front. Yeah, I think, you know -- I think this is more of a speculation that you're seeing in the marketplace more than anything else that we're seeing in our marketplace; it's that because these pricing increases that consumers will be faced with are pretty unprecedented; I mean, these pricing increases are the highest that the industry's seen in about 40 years. Because of the magnitude of these increases within the auto insurance segment that the bundlers which are often referred to as the Robinsons which is a very profitable and desirable segment for, you know, for the entire industry, may be up for grabs because people who are normally bundling their auto and home policies and willing to stick those together or wanting to keep those two together may actually break those apart and shop for separate auto insurance carrier because of the magnitude of the rate increases that they're seeing; I think that will be a really interesting dynamic, right, to see unfold b ecause, you know, that Robinson segment is typically one that doesn't shop around very much, you know, which is one of the reasons that they're so attractive to P&C carriers. If the pricing increases that we're seeing now which really again are unprecedented, really starts to put this segment back into the marketplace to shop for auto insurance rates and they show a willingness to really break apart this auto home bundle; I think that will really lead to a very interesting dynamic and some pricing increases as this very highly desirable consumer segment really comes into play for the first time. Interesting. Appreciate the color. Sure. Thank you, ladies and gentlemen. That does conclude our call. Thank you for your participation, and you may now disconnect.